Dr Bijoyesh Mookerjee steps in as CMO- Oncology for Simcere Pharma

China-based Simcere Pharmaceutical Group has announced the appointment of Dr Bijoyesh Mookerjee as the Chief Medical Officer (CMO), Oncology, of the company. Dr Mookerjee will be responsible for Simcere’s oncology clinical pipeline strategy and development, enhancing the global research capability, as well as advancing the company’s international development. Dr Mookerjee brings over 30 years of oncology, clinical, and medical experience in both academia and the biopharmaceutical industry. Most recently, he was Vice President & Senior Global Programme Clinical Head at Novartis Oncology. Prior to this, he held the role of Executive Director & Global Clinical Programme Head at Novartis Oncology, where he oversaw the clinical activities for multiple cancer programmes during development, franchising, regulatory submissions and interactions, reviews, external acquisitions, and partnerships.